A combination antidiabetic medicine used to manage type 2 diabetes mellitus. Repaglinide helps stimulate insulin release to control blood sugar around meals, while Voglibose slows carbohydrate absorption from the intestine, reducing post-meal glucose spikes. Together, they help maintain better glycemic control when used along with diet and exercise.
VOLTEND-R 0.3 MG TAB
12
Jan